Metavista3D Quote - DDD

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

3.20

Bid

3.16

Offer

3.25

Volume

76,502

3.16 Day's Range 3.34

0.45 52 Week Range 3.34

Market Cap

185.6M

Previous Close

3.18

Open

3.30

Last Trade

1500

3.2

Last Trade Time

03:17:58

Financial Volume

VWAP

Average Volume (3m)

17,109

Shares Outstanding

58,000,000

Dividend Yield

PE Ratio

-2,666.67

Earnings Per Share (EPS)

-0

Revenue

Net Profit

-67k

Sector

Information Retrieval Svcs

Industry

Information Retrieval Svcs

Website

metavista3d.com/#metaverse

Headquarters

Toronto, Ontario, Can

Founded

Metavista3D Inc is listed in the Information Retrieval Svcs sector of the TSX Venture Exchange with ticker DDD. The last closing price for Metavista3D was $3.18. Over the last year, Metavista3D shares have traded in a share price range of $ 0.45 to $ 3.34.

Metavista3D currently has 58,000,000 shares in issue. The market capitalisation of Metavista3D is $184.44 million. Metavista3D has a price to earnings ratio (PE ratio) of -2666.67.

SCOLR Pharma, Inc. Licenses Dietary Supplements

BOTHELL, Wash., Dec. 1 /PRNewswire-FirstCall/ -- SCOLR Pharma, Inc. (NYSE Amex: DDD) announced that on November 20, 2009 it licensed to Chrono Nutraceuticals LLC exclusive rights in Canada to...

SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards

BOTHELL, Wash., Nov. 30 /PRNewswire-FirstCall/ -- SCOLR Pharma, Inc. (NYSE Amex: DDD) announced today that on November 25, 2009, the NYSE Amex LLC (the "Exchange") notified the Company that it...

SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results

BOTHELL, Wash., Nov. 6 /PRNewswire-FirstCall/ -- SCOLR Pharma, Inc. (AMEX: DDD) today reported financial results for the three and nine months ended September 30, 2009. Stephen J. Turner, SCOLR...

SCOLR Pharma, Inc. Receives Notice from NYSE Amex LLC Regarding Compliance Plan and Listing Standards

BOTHELL, Wash., Sept. 18 /PRNewswire-FirstCall/ -- SCOLR Pharma, Inc. (NYSE Amex: DDD) announced today that on September 15, 2009, the NYSE Amex LLC (the "Exchange") accepted the Company's plan...

SCOLR Pharma, Inc. Appoints Stephen J. Turner as CEO

BOTHELL, Wash., Aug. 31 /PRNewswire-FirstCall/ -- SCOLR Pharma, Inc. (NYSE Amex: DDD) announced the appointment of Stephen J. Turner as Chief Executive Officer and President as of August 31...

SCOLR Pharma, Inc. Reports Second Quarter 2009 Financial Results

BOTHELL, Wash., Aug. 7 /PRNewswire-FirstCall/ -- SCOLR Pharma, Inc. (NYSE Amex: DDD) today reported financial results for the three and six months ended June 30, 2009. Dr. Bruce Morra, SCOLR...

SCOLR Pharma, Inc. Reports First Quarter 2009 Financial Results

BOTHELL, Wash., May 1 /PRNewswire-FirstCall/ -- SCOLR Pharma, Inc. (NYSE Amex: DDD) reported financial results for the three months ended March 31, 2009. The Company will host a live conference...

SCOLR Pharma, Inc. Schedules First Quarter 2009 Financial Results Conference Call for May 1, 2009 at 11:30 A.M. Eastern

BOTHELL, Wash., April 29 /PRNewswire-FirstCall/ -- SCOLR Pharma, Inc. (NYSE Alternext US: DDD) today announced plans to release first quarter 2009 financial results on Friday, May 1, 2009, at...

SCOLR Pharma, Inc. Announces Engagement of HealthPro as Financial Advisor

BOTHELL, Wash., April 2 /PRNewswire-FirstCall/ -- SCOLR Pharma, Inc. (NYSE Alternext US: DDD) today announced the engagement of HealthPro BioVentures LLC ("HealthPro"), a life sciences...

SCOLR Pharma, Inc. Reports Fourth Quarter 2008 Financial Results

BOTHELL, Wash., March 11 /PRNewswire-FirstCall/ -- SCOLR Pharma, Inc. (NYSE Alternext US: DDD) today reported financial results for the three and twelve months ended December 31, 2008. The...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	1	45.4545454545	2.2	3.34	2.2	102928	2.97118838	CS
4	1.1	52.380952381	2.1	3.34	1.75	34815	2.90737306	CS
12	2.75	611.111111111	0.45	3.34	0.45	17109	2.3496934	CS
26	2.75	611.111111111	0.45	3.34	0.45	17109	2.3496934	CS
52	2.75	611.111111111	0.45	3.34	0.45	17109	2.3496934	CS
156	2.75	611.111111111	0.45	3.34	0.45	17109	2.3496934	CS
260	2.75	611.111111111	0.45	3.34	0.45	17109	2.3496934	CS

DDD - Frequently Asked Questions (FAQ)

What is the current Metavista3D share price?

The current share price of Metavista3D is $ 3.20

How many Metavista3D shares are in issue?

Metavista3D has 58,000,000 shares in issue

What is the market cap of Metavista3D?

The market capitalisation of Metavista3D is CAD 184.44M

What is the 1 year trading range for Metavista3D share price?

Metavista3D has traded in the range of $ 0.45 to $ 3.34 during the past year

What is the PE ratio of Metavista3D?

The price to earnings ratio of Metavista3D is -2.67k

What is the reporting currency for Metavista3D?

Metavista3D reports financial results in CAD

What is the latest annual profit for Metavista3D?

The latest annual profit of Metavista3D is CAD -67k

What is the registered address of Metavista3D?

The registered address for Metavista3D is 1 ADELAIDE STREET, SUITE 801, TORONTO, ONTARIO, M5C 2V9

What is the Metavista3D website address?

The website address for Metavista3D is metavista3d.com/#metaverse

Which industry sector does Metavista3D operate in?

Metavista3D operates in the INFORMATION RETRIEVAL SVCS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
MVYMoovly Media Inc	$ 0.01 (100.00%)	39k
CTGCentenario Gold Corp	$ 0.02 (100.00%)	650.1k
CTACentaurus Energy Inc	$ 2.90 (63.84%)	4.1k
TOHTotal Helium Ltd	$ 0.015 (50.00%)	3k
KSKlondike Silver Corp	$ 0.015 (50.00%)	118.33k
ADG.HArcus Development Group Inc	$ 0.005 (-66.67%)	11k
TVITVI Pacific Inc	$ 0.005 (-50.00%)	20k
MNLXMiniluxe Holding Corp	$ 0.465 (-38.00%)	4.4k
WAVEWaverley Pharma Inc	$ 0.01 (-33.33%)	4k
MTLOMartello Technologies Group Inc	$ 0.01 (-33.33%)	22k
XBOTRealbotix Corp	$ 0.66 (8.20%)	6.47M
QNCQuantum Emotion Corp	$ 0.70 (-22.22%)	3.65M
WWTWater Ways Technologies Inc	$ 0.005 (0.00%)	2.1M
THRMTherma Bright Inc	$ 0.045 (12.50%)	1.57M
GPUSAlset AI Ventures Inc	$ 0.17 (-8.11%)	1.46M